About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Paternal Age and Fetal Aneuploidy | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT05981521

Paternal Age and Fetal Aneuploidy

Trisomy 21, commonly known as down syndrome, is the most common chromosomal abnormality in humans. Advanced maternal age (AMA) is a well-recognized risk factor for trisomy 21, with the risk increasing...

Lead sponsor: Clinique Ovo•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Clinique Ovo

Age

18 - No limit years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•Pregnant women aged 18 years or older (at the time of trisomy 18 and 21 screening) and who were able to complete the questionnaire in either French or English
•Pregnant women who completed the entire trisomy 21 screening process at clinique ovo were included

Exclusion Criteria

•Patients who did not indicate the male partner/donor's age were excluded
•Patients who did not complete or sign the clinical information form

Related studies

RECRUITINGPhase 3

LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome

NCT07234695 · Down Syndrome, Down Syndrome (DS), and more

Enrolling By Invitation

Qualitative Effects of AEF0217 in Down Syndrome People

NCT07413224 · Down Syndrome (Trisomy 21)

Not Yet Recruiting

Oro-myofunctional Characteristics and Obstructive Sleep Apnea in Infants With Down Syndrome

NCT07195253 · Obstructive Sleep Apnea, Down Syndrome (Trisomy 21)

Not Yet RecruitingPhase 4

Amyloid Lowering for Alzheimer's in Down's With Donanemab Investigation

NCT06911944 · Down Syndrome (DS), Down Syndrome (Trisomy 21), and more

Verification of Risk Assignment for Whole Chromosome Using SNP-based NIPT in Vanishing Twin Pregnancies

NCT05004337 · Vanishing Twin, Trisomy 21, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 9, 2025Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment7,141

Start dateJul 2023

Last updatedDec 9, 2025

Condition

Locations shown

Clinique Ovo

Montreal, Quebec

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 9, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions